Sildenafil Tablet, Film Coated
Product Images NDC 55154-4307

9 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 55154-4307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)
Chemical structure diagram of Sildenafil, showing its molecular framework with various rings and functional groups, consistent with the pharmaceutical compound Sildenafil.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A dot plot chart illustrating fold change and 90% confidence intervals for the area under the curve (AUC) and maximum concentration (Cmax) of sildenafil when coadministered with various interacting drugs. The chart shows changes relative to sildenafil alone, with vertical solid line at 1 indicating no change. Recommendations on dose adjustment or coadministration are listed alongside each drug.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A horizontal dot plot chart showing fold change and 90% confidence intervals for various interacting drugs with Sildenafil. The x-axis represents change relative to interacting drug alone, ranging from 0.5 to 2. The chart lists interacting drugs on the y-axis, including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin (three doses), Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Each drug has fold change data points for AUC and Cmax, with recommendations on dose adjustments or coadministration. Bosentan and Ritonavir are noted as not recommended for coadministration, while others indicate no dose adjustment needed.*
FDA Label Image

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)
A line chart depicting change from baseline in meters over three study weeks (Week 4, Week 8, and Week 12) for four groups: Placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, and Sildenafil 80mg TID. Data points include error bars representing variability across the measurements.*
FDA Label Image

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)
A forest plot chart depicting placebo-corrected changes in 6-minute walk distance in meters for patients treated with Sildenafil 20 mg TID. The chart compares subgroups based on baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index, with point estimates and confidence intervals shown for each subgroup.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A Kaplan-Meier survival curve chart comparing the percentage without a clinically worsening event over days from randomization between placebo and sildenafil groups. The x-axis represents days from randomization up to 112 days, and the y-axis represents the percentage without a clinically worsening event from 0 to 100%. Two lines represent placebo and sildenafil treatments, with sildenafil showing a higher percentage over time.*
FDA Label Image

Pi Logo (Logo1)

FDA Label Image

Logo (Logo mg)

FDA Label Image

20mg Bag Label (487513b4 E663 43d1 Bd09 7eda0247460c 00)

20mg Bag Label (487513b4 E663 43d1 Bd09 7eda0247460c 00)
Label for Sildenafil Tablets USP 20 mg, film-coated oral tablets, packaged with 10 tablets per container. The label details dosage information, storage instructions, and warnings, including that the packaging is not child-resistant and is intended for institutional use only. Manufactured by Torrent Pharmaceuticals Ltd and distributed by Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.